Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing models SEATTLE, Wash. — Pluristyx, Inc. today announced the formation of the Organoid COMMONS (Consortium for Organoid Manufacturing, Measurement, Optimization, and Network for Standards), a public-private consortium created to accelerate the adoption of human-relevant organoid […]
New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is […]
MiniPRO™ – Independent Control of up to 24 Cultures for Scalable, Closed-System Cell Therapy Development CAMARILLO, Calif. — PBS Biotech (“PBS”), a leader in single-use bioreactor technology, today announced the launch of MiniPRO™, a multi-parallel Vertical-Wheel® bioreactor platform. MiniPRO™ is designed to enable high-throughput cell therapy process development for more efficient optimization and scale-up of manufacturing processes. MiniPRO™ will be […]
LONDON — Oxford Instruments announces the release of Imaris 11, the latest generation of its industry-leading 3D/4D microscopy image visualisation and analysis software. The new version introduces an intuitive Workflow system, enhanced batch processing, and advanced tools for object detection and data exploration—designed to help researchers across the region achieve faster, more reproducible, and higher-quality insights. […]
Natick, Mass. – Pillar Biosciences, the leader in Decision Medicine™, today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized its pricing determination for oncoReveal CDx. Following its preliminary decision in August 2025, CMS confirmed a crosswalk-based payment rate of $1,352.09, effective for claims with dates of service on or after January 1, […]
SANTA CLARA, Calif. — Agilent Technologies Inc (NYSE: A) today announced the release of a new 21 CFR Part 11 compliance software for the Agilent xCELLigence Real-Time Cell Analysis (RTCA) eSight system. The software includes a compliance license and enhanced security features, allowing this multiplex live-cell analysis system to be deployed not only in drug discovery and development labs […]
Collaboration to facilitate advanced biologics testing by providing HCP coverage, characterization and quantification assays, and related services to customers globally New center will help improve safety, efficacy, and quality in biopharma development Combination of Cytiva’s analytical technologies with Veeda’s extensive service delivery capabilities and regulatory expertise The Cytiva and Veeda team with Manoj Kumar R […]
Dr. Sebastian Heiner is set to take over the position of CEO of Greiner Bio-One International GmbH on December 1, 2025. Dr. Heiner was most recently a member of the Executive Board at FUCHS SE, and brings with him a wealth of international management experience and expertise in the disciplines of technology development, operational excellence […]
AMSTERDAM Optics11 Life, the commercial-stage company pioneering mechanobiology instrumentation, today announced the appointment of Jacquelien ten Dam as Chief Executive Officer. Jacquelien has a unique combination of commercial expertise and life sciences knowledge to lead the company’s next growth phase. “Jacquelien is exactly what we need at this stage: proven commercial leadership combined with a […]
Vienna, Austria – Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale data generation project producing comprehensive functional genomics datasets from primary human hepatocytes with Ochre Bio. The project included over 120,000 samples assessed with Lexogen’s proprietary extraction-free, high-resolution gene expression profiling platform and NGS Services. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
